Natixis Sanofi Transaction History

Natixis

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$40.43 - $44.3 $658,483 - $721,514	-16,287 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$40.83 - $45.43 $201,700 - $224,424	4,940 Added 43.54%	16,287 $721,000
Q4 2018 Feb 14, 2019	BUY	$41.48 - $45.59 $212,916 - $234,013	5,133 Added 82.6%	11,347 $493,000
Q3 2018 Nov 14, 2018	BUY	$40.0 - $44.84 $35,200 - $39,459	880 Added 16.5%	6,214 $278,000
Q2 2018 Aug 14, 2018	BUY	$37.63 - $41.22 $200,718 - $219,867	5,334 New	5,334 $213,000

805

272M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $135B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.